1,134
Participants
Start Date
September 30, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Tiotropium
Marketed dose
Placebo matching Olodaterol
One dose
Olodaterol
One dose
Tiotropium
Marketed dose
1222.51.01055 Boehringer Ingelheim Investigational Site, Florence
1222.51.01087 Boehringer Ingelheim Investigational Site, Jasper
1222.51.01066 Boehringer Ingelheim Investigational Site, Phoenix
1222.51.01069 Boehringer Ingelheim Investigational Site, Scottsdale
1222.51.01040 Boehringer Ingelheim Investigational Site, Anaheim
1222.51.01064 Boehringer Ingelheim Investigational Site, Encinitas
1222.51.01060 Boehringer Ingelheim Investigational Site, Fullerton
1222.51.01084 Boehringer Ingelheim Investigational Site, Lincoln
1222.51.01041 Boehringer Ingelheim Investigational Site, San Diego
1222.51.01094 Boehringer Ingelheim Investigational Site, San Diego
1222.51.01015 Boehringer Ingelheim Investigational Site, Torrance
1222.51.01052 Boehringer Ingelheim Investigational Site, Boulder
1222.51.01010 Boehringer Ingelheim Investigational Site, Wheat Ridge
1222.51.01042 Boehringer Ingelheim Investigational Site, Wheat Ridge
1222.51.01070 Boehringer Ingelheim Investigational Site, Stamford
1222.51.01006 Boehringer Ingelheim Investigational Site, Clearwater
1222.51.01021 Boehringer Ingelheim Investigational Site, Clearwater
1222.51.01082 Boehringer Ingelheim Investigational Site, Clearwater
1222.51.01065 Boehringer Ingelheim Investigational Site, DeLand
1222.51.01051 Boehringer Ingelheim Investigational Site, Jacksonville
1222.51.01092 Boehringer Ingelheim Investigational Site, Jacksonville
1222.51.01081 Boehringer Ingelheim Investigational Site, Ormond Beach
1222.51.01054 Boehringer Ingelheim Investigational Site, Panama City
1222.51.01062 Boehringer Ingelheim Investigational Site, Pensacola
1222.51.01088 Boehringer Ingelheim Investigational Site, Port Orange
1222.51.01079 Boehringer Ingelheim Investigational Site, Tamarac
1222.51.01075 Boehringer Ingelheim Investigational Site, Atlanta
1222.51.01076 Boehringer Ingelheim Investigational Site, Austell
1222.51.01057 Boehringer Ingelheim Investigational Site, Duluth
1222.51.01086 Boehringer Ingelheim Investigational Site, Lawrenceville
1222.51.01019 Boehringer Ingelheim Investigational Site, Coeur d'Alene
1222.51.01027 Boehringer Ingelheim Investigational Site, Eagle
1222.51.01048 Boehringer Ingelheim Investigational Site, Arlingron Heights
1222.51.01044 Boehringer Ingelheim Investigational Site, River Forest
1222.51.01043 Boehringer Ingelheim Investigational Site, Skokie
1222.51.01090 Boehringer Ingelheim Investigational Site, Louisville
1222.51.01023 Boehringer Ingelheim Investigational Site, Lafayette
1222.51.01071 Boehringer Ingelheim Investigational Site, Opelousas
1222.51.01050 Boehringer Ingelheim Investigational Site, North Dartmouth
1222.51.01049 Boehringer Ingelheim Investigational Site, Ann Arbor
1222.51.01025 Boehringer Ingelheim Investigational Site, Livonia
1222.51.01078 Boehringer Ingelheim Investigational Site, Edina
1222.51.01033 Boehringer Ingelheim Investigational Site, Fridley
1222.51.01074 Boehringer Ingelheim Investigational Site, Saint Charles
1222.51.01037 Boehringer Ingelheim Investigational Site, St Louis
1222.51.01039 Boehringer Ingelheim Investigational Site, Reno
1222.51.01045 Boehringer Ingelheim Investigational Site, Larchmont
1222.51.01018 Boehringer Ingelheim Investigational Site, Rochester
1222.51.01014 Boehringer Ingelheim Investigational Site, Asheville
1222.51.01077 Boehringer Ingelheim Investigational Site, Charlotte
1222.51.01056 Boehringer Ingelheim Investigational Site, Greensboro
1222.51.01032 Boehringer Ingelheim Investigational Site, Canton
1222.51.01011 Boehringer Ingelheim Investigational Site, Cincinnati
1222.51.01005 Boehringer Ingelheim Investigational Site, Columbus
1222.51.01093 Boehringer Ingelheim Investigational Site, Dayton
1222.51.01089 Boehringer Ingelheim Investigational Site, Sylvania
1222.51.01080 Boehringer Ingelheim Investigational Site, Toledo
1222.51.01017 Boehringer Ingelheim Investigational Site, Oklahoma City
1222.51.01047 Boehringer Ingelheim Investigational Site, Tulsa
1222.51.01031 Boehringer Ingelheim Investigational Site, Corvallis
1222.51.01020 Boehringer Ingelheim Investigational Site, Medford
1222.51.01053 Boehringer Ingelheim Investigational Site, Portland
1222.51.01016 Boehringer Ingelheim Investigational Site, Erie
1222.51.01004 Boehringer Ingelheim Investigational Site, Philadelphia
1222.51.01030 Boehringer Ingelheim Investigational Site, East Providence
1222.51.01009 Boehringer Ingelheim Investigational Site, Johnston
1222.51.01036 Boehringer Ingelheim Investigational Site, Charleston
1222.51.01061 Boehringer Ingelheim Investigational Site, Columbia
1222.51.01038 Boehringer Ingelheim Investigational Site, Easley
1222.51.01046 Boehringer Ingelheim Investigational Site, Easley
1222.51.01022 Boehringer Ingelheim Investigational Site, Gaffney
1222.51.01063 Boehringer Ingelheim Investigational Site, Greenville
1222.51.01013 Boehringer Ingelheim Investigational Site, Greer
1222.51.01024 Boehringer Ingelheim Investigational Site, Spartanburg
1222.51.01012 Boehringer Ingelheim Investigational Site, Union
1222.51.01008 Boehringer Ingelheim Investigational Site, Rapid City
1222.51.01035 Boehringer Ingelheim Investigational Site, Johnson City
1222.51.01028 Boehringer Ingelheim Investigational Site, Boerne
1222.51.01083 Boehringer Ingelheim Investigational Site, Corsicana
1222.51.01085 Boehringer Ingelheim Investigational Site, Killeen
1222.51.01073 Boehringer Ingelheim Investigational Site, Longview
1222.51.01003 Boehringer Ingelheim Investigational Site, San Antonio
1222.51.01058 Boehringer Ingelheim Investigational Site, Murray
1222.51.01068 Boehringer Ingelheim Investigational Site, Abingdon
1222.51.01029 Boehringer Ingelheim Investigational Site, Richmond
1222.51.01034 Boehringer Ingelheim Investigational Site, Richmond
1222.51.01072 Boehringer Ingelheim Investigational Site, Richmond
1222.51.01091 Boehringer Ingelheim Investigational Site, Spokane
1222.51.01002 Boehringer Ingelheim Investigational Site, Vancouver
1222.51.01001 Boehringer Ingelheim Investigational Site, Morgantown
Lead Sponsor
Boehringer Ingelheim
INDUSTRY